Enzo Biochem
ENZ
#9227
Rank
S$72.94 M
Marketcap
$1.40
Share price
0.00%
Change (1 day)
-15.04%
Change (1 year)

P/E ratio for Enzo Biochem (ENZ)

P/E ratio as of November 2024 (TTM): -1.10

According to Enzo Biochem's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.10106. At the end of 2022 the company had a P/E ratio of -2.60.

P/E ratio history for Enzo Biochem from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-2.60-108.1%
202132.1-647.74%
2020-5.86-104.46%
2019132-1660.97%
2018-8.42-96.95%
2017-276-3482.81%
20168.16-74.6%
201532.1-280.98%
2014-17.8167.62%
2013-6.64143.33%
2012-2.73-47.65%
2011-5.21-43.76%
2010-9.26-13.91%
2009-10.8-5.38%
2008-11.4-67.87%
2007-35.46.64%
2006-33.2-35.87%
2005-51.8-105.32%
2004973-170.02%
2003< -1000-3193.47%
200244.9-51.43%
200192.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-344 31,130.00%๐Ÿ‡บ๐Ÿ‡ธ USA
23.6-2,245.46%๐Ÿ‡บ๐Ÿ‡ธ USA
31.0-2,918.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-6.83 520.54%๐Ÿ‡บ๐Ÿ‡ธ USA
28.2-2,663.78%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-16.6 1,407.44%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.